Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients

Transplantation

Volumn 73, Issue 3, 2002, Pages 481-482

  Maguire, Donal ^a   Heaton, Nigel D ^a   Smith, Heather M ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; INFECTION RISK; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SEROCONVERSION; TREATMENT FAILURE; VIRUS GENOME; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0037084207     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202150-00027     Document Type: Article

References (10)

1. Hepatitis B, the hidden danger in cadaveric organ donors
2. Hepatitis B virus DNA in mononuclear blood cells
3. Hepatitis B virus DNA containing a glucocorticoid-responsive element
4. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies
5. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: A 10-year prospective study
6. Combination low dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
7. Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation
8. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
9. De novo and apparent de novo hepatitis B virus infection after liver transplantation
10. Clinical and virological profiles in patients with multiple hepatitis virus infections